Actively Recruiting
Argentine Registry Collecting Data on Crohns Disease and Ulcerative Colitis Patients
Led by Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa · Updated on 2025-09-23
4250
Participants Needed
1
Research Sites
108 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to create a comprehensive registry of patients with Inflammatory Bowel Disease IBD in Argentina, including both children and adults. The registry collects detailed demographic, clinical, and diagnostic information from routine medical care to better understand IBD in this population. It also evaluates safety aspects, such as infections, access to healthcare, and treatment effectiveness, including complications like flares, hospitalizations, and surgeries. The registry is observational, involving no experimental treatments or interventions. It is coordinated by multiple committees overseeing administration, scientific initiatives, and methodological support. Physicians across Argentina who manage IBD patients contribute data through a secure web platform. Participation is voluntary for both doctors and patients, with ethical approval and informed consent processes in place to protect patient privacy. Participants contribute data during routine clinical visits, which are uploaded and monitored centrally to ensure quality and completeness. Researchers analyze information on demographics, treatment safety, and clinical outcomes. The registry supports ongoing research projects to address important regional questions on IBD. Participation duration and follow-up depend on routine care, with data collection continuing over time to support epidemiological studies.
CONDITIONS
Brief Title
Argentine Registry of Crohn's Disease and Ulcerative Colitis
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here